Symbol:
TXNDC5
Name:
thioredoxin domain containing 5
RGD ID:
1313292
HGNC Page
HGNC:21073
Description:
Predicted to enable protein disulfide isomerase activity and protein-disulfide reductase activity. Predicted to be involved in protein folding. Located in extracellular exosome.
Type:
protein-coding
RefSeq Status:
REVIEWED
Previously known as:
EndoPDI; endoplasmic reticulum protein ERp46; endoplasmic reticulum resident protein 46; endothelial protein disulphide isomerase; ER protein 46; ERP46; FLJ21789; Hcc-2; HCC2; MGC3178; PDIA15; protein disulfide isomerase family A, member 15; STRF8; thioredoxin domain containing 5 (endoplasmic reticulum); thioredoxin domain-containing protein 5; thioredoxin related protein; thioredoxin-like protein p46; UNQ364
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Txndc5 (thioredoxin domain containing 5)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Txndc5 (thioredoxin domain containing 5)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Chinchilla lanigera (long-tailed chinchilla):
Txndc5 (thioredoxin domain containing 5)
NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
TXNDC5 (thioredoxin domain containing 5)
NCBI
Ortholog
Canis lupus familiaris (dog):
TXNDC5 (thioredoxin domain containing 5)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Txndc5 (thioredoxin domain containing 5)
NCBI
Ortholog
Sus scrofa (pig):
TXNDC5 (thioredoxin domain containing 5)
HGNC
Ensembl, NCBI, OrthoDB
Chlorocebus sabaeus (green monkey):
TXNDC5 (thioredoxin domain containing 5)
NCBI
Ortholog
Heterocephalus glaber (naked mole-rat):
Txndc5 (thioredoxin domain containing 5)
NCBI
Ortholog
Alliance orthologs 3
Mus musculus (house mouse):
Txndc5 (thioredoxin domain containing 5)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Rattus norvegicus (Norway rat):
Txndc5 (thioredoxin domain containing 5)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
txndc5 (thioredoxin domain containing 5)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid|ZFIN)
Drosophila melanogaster (fruit fly):
prtp
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
EPS1
Alliance
DIOPT (Ensembl Compara|PANTHER)
Xenopus laevis (African clawed frog):
txndc5.S
Alliance
DIOPT (Xenbase)
Xenopus tropicalis (tropical clawed frog):
txndc5
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB)
Xenopus laevis (African clawed frog):
txndc5.L
Alliance
DIOPT (Xenbase)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 6 7,881,517 - 7,910,788 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 6 7,881,517 - 7,910,788 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 6 7,881,750 - 7,911,021 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 6 7,826,749 - 8,009,596 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 6 7,826,752 - 7,856,040 NCBI Celera 6 9,111,188 - 9,140,484 (-) NCBI Celera Cytogenetic Map 6 p24.3 NCBI HuRef 6 7,758,572 - 7,787,963 (-) NCBI HuRef CHM1_1 6 7,883,601 - 7,913,171 (-) NCBI CHM1_1 T2T-CHM13v2.0 6 7,750,266 - 7,779,537 (-) NCBI T2T-CHM13v2.0
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
TXNDC5 Human (+)-schisandrin B multiple interactions ISO Txndc5 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TXNDC5 mRNA] CTD PMID:31150632 TXNDC5 Human 1,2-dimethylhydrazine increases expression ISO Txndc5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of TXNDC5 mRNA CTD PMID:22206623 TXNDC5 Human 1,2-dimethylhydrazine multiple interactions ISO Txndc5 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of TXNDC5 mRNA] CTD PMID:22206623 TXNDC5 Human 17beta-estradiol increases expression ISO Txndc5 (Mus musculus) 6480464 Estradiol results in increased expression of TXNDC5 mRNA CTD PMID:39298647 TXNDC5 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of TXNDC5 mRNA CTD PMID:31614463 TXNDC5 Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Txndc5 (Rattus norvegicus) 6480464 2 more ... CTD PMID:21394737 TXNDC5 Human 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Txndc5 (Mus musculus) 6480464 2 more ... CTD PMID:31388691 TXNDC5 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Txndc5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of TXNDC5 mRNA CTD PMID:21570461 TXNDC5 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Txndc5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of TXNDC5 mRNA CTD PMID:34747641 TXNDC5 Human 2,4,6-tribromophenol increases expression EXP 6480464 2 more ... CTD PMID:31675489 TXNDC5 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Txndc5 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 TXNDC5 Human 2,6-dimethoxyphenol multiple interactions EXP 6480464 [Sodium Chloride co-treated with pyrogallol 1 and 3-dimethyl ether] results in decreased expression of TXNDC5 protein CTD PMID:38598786 TXNDC5 Human 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of TXNDC5 protein CTD PMID:31675489 TXNDC5 Human 3,4-methylenedioxymethamphetamine decreases expression ISO Txndc5 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of TXNDC5 mRNA CTD PMID:26251327 TXNDC5 Human 4,4'-diaminodiphenylmethane increases expression ISO Txndc5 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of TXNDC5 mRNA CTD PMID:18648102 TXNDC5 Human 4,4'-sulfonyldiphenol increases expression ISO Txndc5 (Mus musculus) 6480464 bisphenol S results in increased expression of TXNDC5 mRNA CTD PMID:39298647 TXNDC5 Human 4,4'-sulfonyldiphenol multiple interactions ISO Txndc5 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TXNDC5 mRNA CTD PMID:36041667 TXNDC5 Human 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of TXNDC5 protein CTD PMID:34186270 TXNDC5 Human 6-propyl-2-thiouracil decreases expression ISO Txndc5 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of TXNDC5 mRNA CTD PMID:36843608 TXNDC5 Human aflatoxin B1 decreases expression ISO Txndc5 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of TXNDC5 mRNA CTD PMID:19770486 TXNDC5 Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of TXNDC5 mRNA CTD PMID:32234424 TXNDC5 Human aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of TXNDC5 gene CTD PMID:27153756 TXNDC5 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of TXNDC5 mRNA CTD PMID:33167477 TXNDC5 Human ampicillin multiple interactions ISO Txndc5 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein CTD PMID:30545405 TXNDC5 Human antimycin A increases expression EXP 6480464 Antimycin A results in increased expression of TXNDC5 mRNA CTD PMID:33512557 TXNDC5 Human arsane multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC5 mRNA CTD PMID:39836092 TXNDC5 Human arsenic atom multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC5 mRNA CTD PMID:39836092 TXNDC5 Human benzo[a]pyrene decreases expression ISO Txndc5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of TXNDC5 mRNA CTD PMID:19770486 TXNDC5 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of TXNDC5 mRNA CTD PMID:32234424 TXNDC5 Human bis(2-chloroethyl) sulfide decreases expression EXP 6480464 Mustard Gas results in decreased expression of TXNDC5 mRNA CTD PMID:25102026 TXNDC5 Human bis(2-ethylhexyl) phthalate increases expression ISO Txndc5 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of TXNDC5 mRNA CTD PMID:33754040 TXNDC5 Human bis(2-ethylhexyl) phthalate decreases expression ISO Txndc5 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of TXNDC5 mRNA CTD PMID:34319233 TXNDC5 Human bisphenol A decreases expression ISO Txndc5 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of TXNDC5 mRNA CTD PMID:34947998 TXNDC5 Human bisphenol A multiple interactions ISO Txndc5 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TXNDC5 mRNA CTD PMID:36041667 TXNDC5 Human bisphenol A decreases expression ISO Txndc5 (Mus musculus) 6480464 bisphenol A results in decreased expression of TXNDC5 protein CTD PMID:35999755 TXNDC5 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TXNDC5 protein CTD PMID:34186270 TXNDC5 Human bisphenol AF increases expression EXP 6480464 bisphenol AF results in increased expression of TXNDC5 protein CTD PMID:34186270 TXNDC5 Human bisphenol F multiple interactions ISO Txndc5 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TXNDC5 mRNA CTD PMID:36041667 TXNDC5 Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNDC5 mRNA CTD PMID:35301059 TXNDC5 Human cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNDC5 mRNA CTD PMID:35301059 TXNDC5 Human carbon nanotube affects expression ISO Txndc5 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of TXNDC5 protein CTD PMID:21135415 TXNDC5 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to TXNDC5 gene] CTD PMID:28238834 TXNDC5 Human cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of TXNDC5 mRNA CTD PMID:19320972 TXNDC5 Human cobalt dichloride multiple interactions EXP 6480464 [cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of TXNDC5 mRNA and [cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of TXNDC5 protein CTD PMID:23326410 TXNDC5 Human crocidolite asbestos decreases expression ISO Txndc5 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of TXNDC5 mRNA CTD PMID:29279043 TXNDC5 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of TXNDC5 mRNA CTD PMID:20106945 and PMID:21163907 TXNDC5 Human cyclosporin A increases expression ISO Txndc5 (Mus musculus) 6480464 Cyclosporine results in increased expression of TXNDC5 mRNA CTD PMID:25270620 TXNDC5 Human decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of TXNDC5 protein CTD PMID:31675489 TXNDC5 Human deguelin increases expression EXP 6480464 deguelin results in increased expression of TXNDC5 mRNA CTD PMID:33512557 TXNDC5 Human dibutyl phthalate decreases expression ISO Txndc5 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of TXNDC5 protein CTD PMID:34864091 TXNDC5 Human dioxygen multiple interactions EXP 6480464 [cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of TXNDC5 mRNA and [cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of TXNDC5 protein CTD PMID:23326410 TXNDC5 Human diuron decreases expression ISO Txndc5 (Rattus norvegicus) 6480464 Diuron results in decreased expression of TXNDC5 mRNA CTD PMID:21551480 TXNDC5 Human enzyme inhibitor multiple interactions EXP 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TXNDC5 protein CTD PMID:23301498 TXNDC5 Human fenpyroximate increases expression EXP 6480464 fenpyroximate results in increased expression of TXNDC5 mRNA CTD PMID:33512557 TXNDC5 Human fenthion decreases expression ISO Txndc5 (Mus musculus) 6480464 Fenthion results in decreased expression of TXNDC5 mRNA CTD PMID:34813904 TXNDC5 Human folic acid decreases expression ISO Txndc5 (Mus musculus) 6480464 Folic Acid results in decreased expression of TXNDC5 mRNA CTD PMID:25629700 TXNDC5 Human folic acid multiple interactions ISO Txndc5 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of TXNDC5 mRNA] CTD PMID:22206623 TXNDC5 Human furfural multiple interactions EXP 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of TXNDC5 protein CTD PMID:38598786 TXNDC5 Human gentamycin multiple interactions ISO Txndc5 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein CTD PMID:30545405 TXNDC5 Human gold atom multiple interactions ISO Txndc5 (Mus musculus) 6480464 Gold analog results in decreased expression of and results in increased phosphorylation of TXNDC5 protein CTD PMID:24780912 TXNDC5 Human gold(0) multiple interactions ISO Txndc5 (Mus musculus) 6480464 Gold analog results in decreased expression of and results in increased phosphorylation of TXNDC5 protein CTD PMID:24780912 TXNDC5 Human isoprenaline decreases expression ISO Txndc5 (Mus musculus) 6480464 Isoproterenol results in decreased expression of TXNDC5 mRNA CTD PMID:20003209 TXNDC5 Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of TXNDC5 protein CTD PMID:32959892 TXNDC5 Human leptomycin B multiple interactions EXP 6480464 1 and 1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane inhibits the reaction [leptomycin B results in increased expression of TXNDC5 mRNA] CTD PMID:24515801 TXNDC5 Human leptomycin B increases expression EXP 6480464 leptomycin B results in increased expression of TXNDC5 mRNA CTD PMID:24515801 TXNDC5 Human metronidazole multiple interactions ISO Txndc5 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein CTD PMID:30545405 TXNDC5 Human neomycin multiple interactions ISO Txndc5 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein CTD PMID:30545405 TXNDC5 Human nitrates multiple interactions ISO Txndc5 (Mus musculus) 6480464 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TXNDC5 mRNA CTD PMID:35964746 TXNDC5 Human nitric oxide multiple interactions EXP 6480464 [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which affects the expression of TXNDC5 protein CTD PMID:19320461 TXNDC5 Human paracetamol affects expression ISO Txndc5 (Mus musculus) 6480464 Acetaminophen affects the expression of TXNDC5 mRNA CTD PMID:17562736 TXNDC5 Human paracetamol decreases expression ISO Txndc5 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of TXNDC5 mRNA CTD PMID:33387578 TXNDC5 Human paracetamol increases expression ISO Txndc5 (Mus musculus) 6480464 Acetaminophen results in increased expression of TXNDC5 mRNA CTD PMID:29246445 TXNDC5 Human paracetamol multiple interactions ISO Txndc5 (Mus musculus) 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of TXNDC5 mRNA] CTD PMID:29246445 TXNDC5 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Txndc5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of TXNDC5 mRNA CTD PMID:36331819 TXNDC5 Human pirinixic acid increases expression ISO Txndc5 (Mus musculus) 6480464 pirinixic acid results in increased expression of TXNDC5 mRNA CTD PMID:18301758 TXNDC5 Human pyrimidifen increases expression EXP 6480464 pyrimidifen results in increased expression of TXNDC5 mRNA CTD PMID:33512557 TXNDC5 Human quinoline decreases expression EXP 6480464 quinoline analog results in decreased expression of TXNDC5 protein CTD PMID:18645022 TXNDC5 Human SB 431542 multiple interactions EXP 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TXNDC5 protein CTD PMID:37664457 TXNDC5 Human sertraline decreases expression EXP 6480464 Sertraline results in decreased expression of TXNDC5 mRNA CTD PMID:24865413 TXNDC5 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of TXNDC5 mRNA CTD PMID:24516582 and PMID:38568856 TXNDC5 Human sodium arsenite multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC5 mRNA CTD PMID:39836092 TXNDC5 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of TXNDC5 protein CTD PMID:20050688 TXNDC5 Human sodium chloride multiple interactions EXP 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of TXNDC5 protein more ... CTD PMID:38598786 TXNDC5 Human tebufenpyrad increases expression EXP 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of TXNDC5 mRNA CTD PMID:33512557 TXNDC5 Human testosterone decreases expression ISO Txndc5 (Mus musculus) 6480464 Testosterone deficiency results in decreased expression of TXNDC5 mRNA CTD PMID:33848595 TXNDC5 Human tetrachloromethane increases expression ISO Txndc5 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of TXNDC5 mRNA CTD PMID:31150632 TXNDC5 Human tetrachloromethane increases expression ISO Txndc5 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of TXNDC5 mRNA CTD PMID:31919559 TXNDC5 Human tetrachloromethane multiple interactions ISO Txndc5 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TXNDC5 mRNA] CTD PMID:31150632 TXNDC5 Human thifluzamide increases expression EXP 6480464 thifluzamide results in increased expression of TXNDC5 mRNA CTD PMID:33512557 TXNDC5 Human titanium dioxide decreases expression ISO Txndc5 (Mus musculus) 6480464 titanium dioxide results in decreased expression of TXNDC5 mRNA CTD PMID:29264374 TXNDC5 Human titanium dioxide decreases methylation ISO Txndc5 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of TXNDC5 gene CTD PMID:35295148 TXNDC5 Human trimellitic anhydride increases expression ISO Txndc5 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of TXNDC5 mRNA CTD PMID:19042947 TXNDC5 Human valproic acid decreases expression ISO Txndc5 (Mus musculus) 6480464 Valproic Acid results in decreased expression of TXNDC5 mRNA CTD PMID:21427059 TXNDC5 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of TXNDC5 mRNA CTD PMID:25979313 TXNDC5 Human vancomycin multiple interactions ISO Txndc5 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein CTD PMID:30545405 TXNDC5 Human zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of TXNDC5 mRNA CTD PMID:22171008 TXNDC5 Human zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of TXNDC5 mRNA CTD PMID:22171008
Imported Annotations - KEGG (archival)
(+)-schisandrin B (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (EXP,ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3',4,4',5-Pentachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (ISO) 2,4,6-tribromophenol (EXP) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 2,6-dimethoxyphenol (EXP) 3,3',5,5'-tetrabromobisphenol A (EXP) 3,4-methylenedioxymethamphetamine (ISO) 4,4'-diaminodiphenylmethane (ISO) 4,4'-sulfonyldiphenol (EXP,ISO) 6-propyl-2-thiouracil (ISO) aflatoxin B1 (EXP,ISO) all-trans-retinoic acid (EXP) ampicillin (ISO) antimycin A (EXP) arsane (EXP) arsenic atom (EXP) benzo[a]pyrene (EXP,ISO) bis(2-chloroethyl) sulfide (EXP) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol AF (EXP) bisphenol F (ISO) cadmium atom (EXP) cadmium dichloride (EXP) carbon nanotube (ISO) CGP 52608 (EXP) cobalt dichloride (EXP) crocidolite asbestos (ISO) cyclosporin A (EXP,ISO) decabromodiphenyl ether (EXP) deguelin (EXP) dibutyl phthalate (ISO) dioxygen (EXP) diuron (ISO) enzyme inhibitor (EXP) fenpyroximate (EXP) fenthion (ISO) folic acid (ISO) furfural (EXP) gentamycin (ISO) gold atom (ISO) gold(0) (ISO) isoprenaline (ISO) ivermectin (EXP) leptomycin B (EXP) metronidazole (ISO) neomycin (ISO) nitrates (ISO) nitric oxide (EXP) paracetamol (ISO) perfluorooctane-1-sulfonic acid (ISO) pirinixic acid (ISO) pyrimidifen (EXP) quinoline (EXP) SB 431542 (EXP) sertraline (EXP) sodium arsenite (EXP) sodium chloride (EXP) tebufenpyrad (EXP) testosterone (ISO) tetrachloromethane (ISO) thifluzamide (EXP) titanium dioxide (ISO) trimellitic anhydride (ISO) valproic acid (EXP,ISO) vancomycin (ISO) zinc atom (EXP) zinc(0) (EXP)
TXNDC5 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 6 7,881,517 - 7,910,788 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 6 7,881,517 - 7,910,788 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 6 7,881,750 - 7,911,021 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 6 7,826,749 - 8,009,596 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 6 7,826,752 - 7,856,040 NCBI Celera 6 9,111,188 - 9,140,484 (-) NCBI Celera Cytogenetic Map 6 p24.3 NCBI HuRef 6 7,758,572 - 7,787,963 (-) NCBI HuRef CHM1_1 6 7,883,601 - 7,913,171 (-) NCBI CHM1_1 T2T-CHM13v2.0 6 7,750,266 - 7,779,537 (-) NCBI T2T-CHM13v2.0
Txndc5 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 13 38,684,242 - 38,712,800 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 13 38,684,055 - 38,712,800 (-) Ensembl GRCm39 Ensembl GRCm38 13 38,500,266 - 38,528,824 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 13 38,500,079 - 38,528,824 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 13 38,592,144 - 38,620,329 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 13 38,507,741 - 38,535,926 (-) NCBI MGSCv36 mm8 Celera 13 39,616,452 - 39,644,639 (-) NCBI Celera Cytogenetic Map 13 A3.3 NCBI cM Map 13 18.27 NCBI
Txndc5 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 17 26,495,467 - 26,523,608 (+) NCBI GRCr8 mRatBN7.2 17 26,289,880 - 26,318,025 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 17 26,289,880 - 26,318,025 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 17 26,147,696 - 26,175,806 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 17 27,751,281 - 27,779,392 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 17 26,096,561 - 26,124,693 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 17 26,925,828 - 26,953,981 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 17 26,925,828 - 26,953,970 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 17 28,841,031 - 28,869,184 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 17 32,350,902 - 32,378,321 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 17 32,353,771 - 32,381,879 (+) NCBI Celera 17 25,925,724 - 25,953,865 (+) NCBI Celera Cytogenetic Map 17 p12 NCBI
Txndc5 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955465 6,033,968 - 6,053,769 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955465 6,034,006 - 6,053,779 (+) NCBI ChiLan1.0 ChiLan1.0
TXNDC5 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 5 22,522,351 - 22,551,966 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 6 18,519,349 - 18,548,868 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 6 7,720,141 - 7,749,672 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 6 8,001,831 - 8,025,284 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 6 8,001,831 - 8,027,408 (-) Ensembl panpan1.1 panPan2
TXNDC5 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 35 7,834,135 - 7,854,836 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 35 7,834,331 - 7,854,852 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 35 7,841,150 - 7,865,571 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 35 7,916,645 - 7,942,933 (-) NCBI ROS_Cfam_1.0 UMICH_Zoey_3.1 35 7,773,396 - 7,798,132 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 35 7,799,357 - 7,825,378 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 35 9,132,754 - 9,158,894 (-) NCBI UU_Cfam_GSD_1.0
Txndc5 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404946 16,410,650 - 16,438,740 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936534 4,679,631 - 4,706,309 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936534 4,679,636 - 4,706,682 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
TXNDC5 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 7 5,210,064 - 5,236,812 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 7 5,210,192 - 5,236,857 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 7 5,314,558 - 5,323,063 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
TXNDC5 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 17 64,250,319 - 64,278,102 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 17 64,250,359 - 64,281,195 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666044 7,873,712 - 7,902,752 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Txndc5 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 3091 Count of miRNA genes: 788 Interacting mature miRNAs: 883 Transcripts: ENST00000379757, ENST00000460138, ENST00000469459, ENST00000473453, ENST00000475802, ENST00000539054 Prediction methods: Microtar, Miranda, Rnahybrid Result types: miRGate_prediction
597476412 GWAS1572486_H blood protein measurement QTL GWAS1572486 (human) 3e-21 blood protein amount (VT:0005416) blood protein measurement (CMO:0000028) 6 7883235 7883236 Human 2289408 BW324_H Body weight QTL 324 (human) 3.15 0.0001 Body fat amount 6 1 20803913 Human 597362425 GWAS1458499_H blood protein measurement QTL GWAS1458499 (human) 2e-12 blood protein amount (VT:0005416) blood protein measurement (CMO:0000028) 6 7899503 7899504 Human 1643418 BW282_H Body Weight QTL 282 (human) 2.07 0.001 Body weight 6 1 19321359 Human 597445019 GWAS1541093_H thioredoxin domain-containing protein 5 measurement QTL GWAS1541093 (human) 5e-27 thioredoxin domain-containing protein 5 measurement 6 7883235 7883236 Human 1643377 BW325_H Body weight QTL 325 (human) 2.32 0.0005 Body fat amount 6 6911960 32911960 Human 1643569 GLUCO21_H Glucose level QTL 21 (human) 0.021 Glucose level non-insulin-dependent 6 6911960 32911960 Human 1298458 BW9_H Body weight QTL 9 (human) 2.7 0.0002 Body fat amount 6 6911960 32911960 Human 2289320 BW390_H Body weight QTL 390 (human) 2.13 Body weight BMI 6 1 19321359 Human 597322484 GWAS1418558_H level of thioredoxin domain-containing protein 5 in blood serum QTL GWAS1418558 (human) 3e-12 level of thioredoxin domain-containing protein 5 in blood serum 6 7881919 7881920 Human 1358854 MULTSCL4_H Multiple sclerosis susceptibility QTL 4 (human) Multiple sclerosis susceptibility 6 6911960 32911960 Human 597176844 GWAS1272918_H thioredoxin domain-containing protein 5 measurement QTL GWAS1272918 (human) 1e-45 thioredoxin domain-containing protein 5 measurement 6 7887106 7887111 Human 2289435 BMD4_H Bone mineral density QTL 4 (human) 3.15 0.0001 Bone mineral density 6 1 20803913 Human 2292824 PRSTS5_H Prostate tumor susceptibility QTL 5 (human) Prostate tumor susceptibility 6 1 19232373 Human 597432294 GWAS1528368_H protein measurement QTL GWAS1528368 (human) 2e-15 protein measurement 6 7883235 7883236 Human 596978377 GWAS1097896_H body height QTL GWAS1097896 (human) 6e-11 body height 6 7881698 7881699 Human 597510880 GWAS1606954_H level of thioredoxin domain-containing protein 5 in blood serum QTL GWAS1606954 (human) 8e-20 level of thioredoxin domain-containing protein 5 in blood serum 6 7883235 7883236 Human 1643495 BW291_H Body Weight QTL 291 (human) 2.13 Body weight BMI 6 1 19321359 Human 1643399 BMD5_H Bone mineral density QTL 5 (human) 2.32 0.0005 Bone mineral density 6 6911960 32911960 Human
A002L04
Human Assembly Chr Position (strand) Source JBrowse GRCh37 6 7,881,912 - 7,882,028 UniSTS GRCh37 Build 36 6 7,826,911 - 7,827,027 RGD NCBI36 Celera 6 9,111,350 - 9,111,466 RGD Cytogenetic Map 6 p24.3 UniSTS Cytogenetic Map 6 p24-p23 UniSTS Cytogenetic Map 6 p UniSTS HuRef 6 7,758,990 - 7,759,106 UniSTS GeneMap99-GB4 RH Map 6 40.68 UniSTS GeneMap99-GB4 RH Map 6 43.85 UniSTS Whitehead-RH Map 6 65.7 UniSTS
WI-13193
Human Assembly Chr Position (strand) Source JBrowse GRCh37 6 7,881,799 - 7,881,902 UniSTS GRCh37 Build 36 6 7,826,798 - 7,826,901 RGD NCBI36 Celera 6 9,111,237 - 9,111,340 RGD Cytogenetic Map 6 p UniSTS Cytogenetic Map 6 p24.3 UniSTS Cytogenetic Map 6 p24-p23 UniSTS HuRef 6 7,758,888 - 7,758,980 UniSTS GeneMap99-GB4 RH Map 6 40.68 UniSTS Whitehead-RH Map 6 65.8 UniSTS
RH26506
Human Assembly Chr Position (strand) Source JBrowse GRCh37 6 7,890,998 - 7,891,181 UniSTS GRCh37 Build 36 6 7,835,997 - 7,836,180 RGD NCBI36 Celera 6 9,120,439 - 9,120,622 RGD Cytogenetic Map 6 p24.3 UniSTS HuRef 6 7,768,075 - 7,768,258 UniSTS
NIB594
Human Assembly Chr Position (strand) Source JBrowse GRCh37 6 7,881,839 - 7,882,061 UniSTS GRCh37 Build 36 6 7,826,838 - 7,827,060 RGD NCBI36 Celera 6 9,111,277 - 9,111,499 RGD Cytogenetic Map 6 p24-p23 UniSTS Cytogenetic Map 6 p24.3 UniSTS Stanford-G3 RH Map 6 247.0 UniSTS GeneMap99-G3 RH Map 6 247.0 UniSTS
RH46813
Human Assembly Chr Position (strand) Source JBrowse GRCh37 6 7,891,006 - 7,891,131 UniSTS GRCh37 Build 36 6 7,836,005 - 7,836,130 RGD NCBI36 Celera 6 9,120,447 - 9,120,572 RGD Cytogenetic Map 6 p24.3 UniSTS HuRef 6 7,768,083 - 7,768,208 UniSTS GeneMap99-GB4 RH Map 6 42.91 UniSTS NCBI RH Map 6 105.1 UniSTS
AL021859
Human Assembly Chr Position (strand) Source JBrowse GRCh37 6 7,884,815 - 7,884,972 UniSTS GRCh37 Build 36 6 7,829,814 - 7,829,971 RGD NCBI36 Celera 6 9,114,253 - 9,114,410 RGD Cytogenetic Map 6 p24.3 UniSTS HuRef 6 7,761,889 - 7,762,046 UniSTS
SHGC-33534
Human Assembly Chr Position (strand) Source JBrowse GRCh37 6 7,890,904 - 7,891,028 UniSTS GRCh37 Build 36 6 7,835,903 - 7,836,027 RGD NCBI36 Celera 6 9,120,345 - 9,120,469 RGD Cytogenetic Map 6 p24.3 UniSTS HuRef 6 7,767,981 - 7,768,105 UniSTS Stanford-G3 RH Map 6 235.0 UniSTS GeneMap99-GB4 RH Map 6 43.85 UniSTS Whitehead-RH Map 6 61.3 UniSTS NCBI RH Map 6 112.7 UniSTS GeneMap99-G3 RH Map 6 235.0 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
entire extraembryonic component
1204
2439
2788
2250
4971
1726
2351
6
624
1948
465
2270
7297
6463
53
3731
1
852
1744
1617
174
1
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENST00000379757 ⟹ ENSP00000369081
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 6 7,881,517 - 7,910,788 (-) Ensembl
Ensembl Acc Id:
ENST00000460138
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 6 7,881,517 - 7,889,445 (-) Ensembl
Ensembl Acc Id:
ENST00000469459
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 6 7,895,155 - 7,900,242 (-) Ensembl
Ensembl Acc Id:
ENST00000473453 ⟹ ENSP00000420784
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 6 7,883,144 - 7,910,077 (-) Ensembl
Ensembl Acc Id:
ENST00000475802
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 6 7,883,155 - 7,888,961 (-) Ensembl
RefSeq Acc Id:
NM_001145549 ⟹ NP_001139021
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 6 7,881,517 - 7,910,077 (-) NCBI GRCh37 6 7,881,483 - 7,911,047 (-) ENTREZGENE HuRef 6 7,758,572 - 7,787,963 (-) ENTREZGENE CHM1_1 6 7,883,601 - 7,912,434 (-) NCBI T2T-CHM13v2.0 6 7,750,266 - 7,778,826 (-) NCBI
Sequence:
AATTCAACCGCCTCTTGCACCTCGGCACCGAGGGAGGGGAAGGTGGGGTCGTCGCCCTTTCGGGCAGCCGGGAGTCCAAATGTCACCCCGCGGTCCCTGCCCAGCGCCCCAAACTTCCTGTGCCGGCC GGACGCGCGGCCTGCCCGTGGGCCACGTGCACTCACCAGAGCGGCCTTGCTGCTGCCGCGGCCACCGGGGTCGGCTGGGACAGACTGCGGGCACGTCCCCTTCCAGAGGCTTTAACTGAAAAATAGAA CCCAGGAAGGTGTGGACACTGCCAGCGGCTGCAGCCGACTTGGAATGACCTGGGAGACAAATACAACAGCATGGAAGATGCCAAAGTCTATGTGGCTAAAGTGGACTGCACGGCCCACTCCGACGTGT GCTCCGCCCAGGGGGTGCGAGGATACCCCACCTTAAAGCTTTTCAAGCCAGGCCAAGAAGCTGTGAAGTACCAGGGTCCTCGGGACTTCCAGACACTGGAAAACTGGATGCTGCAGACACTGAACGAG GAGCCAGTGACACCAGAGCCGGAAGTGGAACCGCCCAGTGCCCCCGAGCTCAAGCAAGGGCTGTATGAGCTCTCAGCAAGCAACTTTGAGCTGCACGTTGCACAAGGCGACCACTTTATCAAGTTCTT CGCTCCGTGGTGTGGTCACTGCAAAGCCCTGGCTCCAACCTGGGAGCAGCTGGCTCTGGGCCTTGAACATTCCGAAACTGTCAAGATTGGCAAGGTTGATTGTACACAGCACTATGAACTCTGCTCCG GAAACCAGGTTCGTGGCTATCCCACTCTTCTCTGGTTCCGAGATGGGAAAAAGGTGGATCAGTACAAGGGAAAGCGGGATTTGGAGTCACTGAGGGAGTACGTGGAGTCGCAGCTGCAGCGCACAGAG ACTGGAGCGACGGAGACCGTCACGCCCTCAGAGGCCCCGGTGCTGGCAGCTGAGCCCGAGGCTGACAAGGGCACTGTGTTGGCACTCACTGAAAATAACTTCGATGACACCATTGCAGAAGGAATAAC CTTCATCAAGTTTTATGCTCCATGGTGTGGTCATTGTAAGACTCTGGCTCCTACTTGGGAGGAACTCTCTAAAAAGGAATTCCCTGGTCTGGCGGGGGTCAAGATCGCCGAAGTAGACTGCACTGCTG AACGGAATATCTGCAGCAAGTATTCGGTACGAGGCTACCCCACGTTATTGCTTTTCCGAGGAGGGAAGAAAGTCAGTGAGCACAGTGGAGGCAGAGACCTTGACTCGTTACACCGCTTTGTCCTGAGC CAAGCGAAAGACGAACTTTAGGAACACAGTTGGAGGTCACCTCTCCTGCCCAGCTCCCGCACCCTGCGTTTAGGAGTTCAGTCCCACAGAGGCCACTGGGTTCCCAGTGGTGGCTGTTCAGAAAGCAG AACATACTAAGCGTGAGGTATCTTCTTTGTGTGTGTGTTTTCCAAGCCAACACACTCTACAGATTCTTTATTAAGTTAAGTTTCTCTAAGTAAATGTGTAACTCATGGTCACTGTGTAAACATTTTCA GTGGCGATATATCCCCTTTGACCTTCTCTTGATGAAATTTACATGGTTTCCTTTGAGACTAAAATAGCGTTGAGGGAAATGAAATTGCTGGACTATTTGTGGCTCCTGAGTTGAGTGATTTTGGTGAA AGAAAGCACATCCAAAGCATAGTTTACCTGCCCACGAGTTCTGGAAAGGTGGCCTTGTGGCAGTATTGACGTTCCTCTGATCTTAAGGTCACAGTTGACTCAATACTGTGTTGGTCCGTAGCATGGAG CAGATTGAAATGCAAAAACCCACACCTCTGGAAGATACCTTCACGGCCGCTGCTGGAGCTTCTGTTGCTGTGAATACTTCTCTCAGTGTGAGAGGTTAGCCGTGATGAAAGCAGCGTTACTTCTGACC GTGCCTGAGTAAGAGAATGCTGATGCCATAACTTTATGTGTCGATACTTGTCAAATCAGTTACTGTTCAGGGGATCCTTCTGTTTCTCACGGGGTGAAACATGTCTTTAGTTCCTCATGTTAACACGA AGCCAGAGCCCACATGAACTGTTGGATGTCTTCCTTAGAAAGGGTAGGCATGGAAAATTCCACGAGGCTCATTCTCAGTATCTCATTAACTCATTGAAAGATTCCAGTTGTATTTGTCACCTGGGGTG ACAAGACCAGACAGGCTTTCCCAGGCCTGGGTATCCAGGGAGGCTCTGCAGCCCTGCTGAAGGGCCCTAACTAGAGTTCTAGAGTTTCTGATTCTGTTTCTCAGTAGTCCTTTTAGAGGCTTGCTATA CTTGGTCTGCTTCAAGGAGGTCGACCTTCTAATGTATGAAGAATGGGATGCATTTGATCTCAAGACCAAAGACAGATGTCAGTGGGCTGCTCTGGCCCTGGTGTGCACGGCTGTGGCAGCTGTTGATG CCAGTGTCCTCTAACTCATGCTGTCCTTGTGATTAAACACCTCTATCTCCCTTGGGAATAAGCACATACAGGCTTAAGCTCTAAGATAGATAGGTGTTTGTCCTTTTACCATCGAGCTACTTCCCATA ATAACCACTTTGCATCCAACACTCTTCACCCACCTCCCATACGCAAGGGGATGTGGATACTTGGCCCAAAGTAACTGGTGGTAGGAATCTTAGAAACAAGACCACTTATACTGTCTGTCTGAGGCAGA AGATAACAGCAGCATCTCGACCAGCCTCTGCCTTAAAGGAAATCTTTATTAATCACGTATGGTTCACAGATAATTCTTTTTTTAAAAAAACCCAACCTCCTAGAGAAGCACAACTGTCAAGAGTCTTG TACACACAACTTCAGCTTTGCATCACGAGTCTTGTATTCCAAGAAAATCAAAGTGGTACAATTTGTTTGTTTACACTATGATACTTTCTAAATAAACTCTTTTTTTTTAAAA
hide sequence
RefSeq Acc Id:
NM_030810 ⟹ NP_110437
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 6 7,881,517 - 7,910,788 (-) NCBI GRCh37 6 7,881,483 - 7,911,047 (-) NCBI Build 36 6 7,826,749 - 7,856,040 (-) NCBI Archive HuRef 6 7,758,572 - 7,787,963 (-) ENTREZGENE CHM1_1 6 7,883,601 - 7,913,171 (-) NCBI T2T-CHM13v2.0 6 7,750,266 - 7,779,537 (-) NCBI
Sequence:
AGCCCCGCCGCGATGCCCGCGCGCCCAGGACGCCTCCTCCCGCTGCTGGCCCGGCCGGCGGCCCTGACTGCGCTGCTGCTGCTGCTGCTGGGCCATGGCGGCGGCGGGCGCTGGGGCGCCCGGGCCCA GGAGGCGGCGGCGGCGGCGGCGGACGGGCCCCCCGCGGCAGACGGCGAGGACGGACAGGACCCGCACAGCAAGCACCTGTACACGGCCGACATGTTCACGCACGGGATCCAGAGCGCCGCGCACTTCG TCATGTTCTTCGCGCCCTGGTGTGGACACTGCCAGCGGCTGCAGCCGACTTGGAATGACCTGGGAGACAAATACAACAGCATGGAAGATGCCAAAGTCTATGTGGCTAAAGTGGACTGCACGGCCCAC TCCGACGTGTGCTCCGCCCAGGGGGTGCGAGGATACCCCACCTTAAAGCTTTTCAAGCCAGGCCAAGAAGCTGTGAAGTACCAGGGTCCTCGGGACTTCCAGACACTGGAAAACTGGATGCTGCAGAC ACTGAACGAGGAGCCAGTGACACCAGAGCCGGAAGTGGAACCGCCCAGTGCCCCCGAGCTCAAGCAAGGGCTGTATGAGCTCTCAGCAAGCAACTTTGAGCTGCACGTTGCACAAGGCGACCACTTTA TCAAGTTCTTCGCTCCGTGGTGTGGTCACTGCAAAGCCCTGGCTCCAACCTGGGAGCAGCTGGCTCTGGGCCTTGAACATTCCGAAACTGTCAAGATTGGCAAGGTTGATTGTACACAGCACTATGAA CTCTGCTCCGGAAACCAGGTTCGTGGCTATCCCACTCTTCTCTGGTTCCGAGATGGGAAAAAGGTGGATCAGTACAAGGGAAAGCGGGATTTGGAGTCACTGAGGGAGTACGTGGAGTCGCAGCTGCA GCGCACAGAGACTGGAGCGACGGAGACCGTCACGCCCTCAGAGGCCCCGGTGCTGGCAGCTGAGCCCGAGGCTGACAAGGGCACTGTGTTGGCACTCACTGAAAATAACTTCGATGACACCATTGCAG AAGGAATAACCTTCATCAAGTTTTATGCTCCATGGTGTGGTCATTGTAAGACTCTGGCTCCTACTTGGGAGGAACTCTCTAAAAAGGAATTCCCTGGTCTGGCGGGGGTCAAGATCGCCGAAGTAGAC TGCACTGCTGAACGGAATATCTGCAGCAAGTATTCGGTACGAGGCTACCCCACGTTATTGCTTTTCCGAGGAGGGAAGAAAGTCAGTGAGCACAGTGGAGGCAGAGACCTTGACTCGTTACACCGCTT TGTCCTGAGCCAAGCGAAAGACGAACTTTAGGAACACAGTTGGAGGTCACCTCTCCTGCCCAGCTCCCGCACCCTGCGTTTAGGAGTTCAGTCCCACAGAGGCCACTGGGTTCCCAGTGGTGGCTGTT CAGAAAGCAGAACATACTAAGCGTGAGGTATCTTCTTTGTGTGTGTGTTTTCCAAGCCAACACACTCTACAGATTCTTTATTAAGTTAAGTTTCTCTAAGTAAATGTGTAACTCATGGTCACTGTGTA AACATTTTCAGTGGCGATATATCCCCTTTGACCTTCTCTTGATGAAATTTACATGGTTTCCTTTGAGACTAAAATAGCGTTGAGGGAAATGAAATTGCTGGACTATTTGTGGCTCCTGAGTTGAGTGA TTTTGGTGAAAGAAAGCACATCCAAAGCATAGTTTACCTGCCCACGAGTTCTGGAAAGGTGGCCTTGTGGCAGTATTGACGTTCCTCTGATCTTAAGGTCACAGTTGACTCAATACTGTGTTGGTCCG TAGCATGGAGCAGATTGAAATGCAAAAACCCACACCTCTGGAAGATACCTTCACGGCCGCTGCTGGAGCTTCTGTTGCTGTGAATACTTCTCTCAGTGTGAGAGGTTAGCCGTGATGAAAGCAGCGTT ACTTCTGACCGTGCCTGAGTAAGAGAATGCTGATGCCATAACTTTATGTGTCGATACTTGTCAAATCAGTTACTGTTCAGGGGATCCTTCTGTTTCTCACGGGGTGAAACATGTCTTTAGTTCCTCAT GTTAACACGAAGCCAGAGCCCACATGAACTGTTGGATGTCTTCCTTAGAAAGGGTAGGCATGGAAAATTCCACGAGGCTCATTCTCAGTATCTCATTAACTCATTGAAAGATTCCAGTTGTATTTGTC ACCTGGGGTGACAAGACCAGACAGGCTTTCCCAGGCCTGGGTATCCAGGGAGGCTCTGCAGCCCTGCTGAAGGGCCCTAACTAGAGTTCTAGAGTTTCTGATTCTGTTTCTCAGTAGTCCTTTTAGAG GCTTGCTATACTTGGTCTGCTTCAAGGAGGTCGACCTTCTAATGTATGAAGAATGGGATGCATTTGATCTCAAGACCAAAGACAGATGTCAGTGGGCTGCTCTGGCCCTGGTGTGCACGGCTGTGGCA GCTGTTGATGCCAGTGTCCTCTAACTCATGCTGTCCTTGTGATTAAACACCTCTATCTCCCTTGGGAATAAGCACATACAGGCTTAAGCTCTAAGATAGATAGGTGTTTGTCCTTTTACCATCGAGCT ACTTCCCATAATAACCACTTTGCATCCAACACTCTTCACCCACCTCCCATACGCAAGGGGATGTGGATACTTGGCCCAAAGTAACTGGTGGTAGGAATCTTAGAAACAAGACCACTTATACTGTCTGT CTGAGGCAGAAGATAACAGCAGCATCTCGACCAGCCTCTGCCTTAAAGGAAATCTTTATTAATCACGTATGGTTCACAGATAATTCTTTTTTTAAAAAAACCCAACCTCCTAGAGAAGCACAACTGTC AAGAGTCTTGTACACACAACTTCAGCTTTGCATCACGAGTCTTGTATTCCAAGAAAATCAAAGTGGTACAATTTGTTTGTTTACACTATGATACTTTCTAAATAAACTCTTTTTTTTTAAAA
hide sequence
RefSeq Acc Id:
NP_110437 ⟸ NM_030810
- Peptide Label:
isoform 1 precursor
- UniProtKB:
Q8TCT2 (UniProtKB/Swiss-Prot), Q8ND33 (UniProtKB/Swiss-Prot), Q5TCQ0 (UniProtKB/Swiss-Prot), B2RDM2 (UniProtKB/Swiss-Prot), Q9BVH9 (UniProtKB/Swiss-Prot), Q8NBS9 (UniProtKB/Swiss-Prot), Q658S9 (UniProtKB/TrEMBL)
- Sequence:
MPARPGRLLPLLARPAALTALLLLLLGHGGGGRWGARAQEAAAAAADGPPAADGEDGQDPHSKHLYTADMFTHGIQSAAHFVMFFAPWCGHCQRLQPTWNDLGDKYNSMEDAKVYVAKVDCTAHSDVC SAQGVRGYPTLKLFKPGQEAVKYQGPRDFQTLENWMLQTLNEEPVTPEPEVEPPSAPELKQGLYELSASNFELHVAQGDHFIKFFAPWCGHCKALAPTWEQLALGLEHSETVKIGKVDCTQHYELCSG NQVRGYPTLLWFRDGKKVDQYKGKRDLESLREYVESQLQRTETGATETVTPSEAPVLAAEPEADKGTVLALTENNFDDTIAEGITFIKFYAPWCGHCKTLAPTWEELSKKEFPGLAGVKIAEVDCTAE RNICSKYSVRGYPTLLLFRGGKKVSEHSGGRDLDSLHRFVLSQAKDEL
hide sequence
RefSeq Acc Id:
NP_001139021 ⟸ NM_001145549
- Peptide Label:
isoform 3
- UniProtKB:
A0A024QZV0 (UniProtKB/TrEMBL), Q86UY0 (UniProtKB/TrEMBL)
- Sequence:
MEDAKVYVAKVDCTAHSDVCSAQGVRGYPTLKLFKPGQEAVKYQGPRDFQTLENWMLQTLNEEP VTPEPEVEPPSAPELKQGLYELSASNFELHVAQGDHFIKFFAPWCGHCKALAPTWEQLALGLEHSETVKIGKVDCTQHYELCSGNQVRGYPTLLWFRDGKKVDQYKGKRDLESLREYVESQLQRTETG ATETVTPSEAPVLAAEPEADKGTVLALTENNFDDTIAEGITFIKFYAPWCGHCKTLAPTWEELSKKEFPGLAGVKIAEVDCTAERNICSKYSVRGYPTLLLFRGGKKVSEHSGGRDLDSLHRFVLSQA KDEL
hide sequence
Ensembl Acc Id:
ENSP00000369081 ⟸ ENST00000379757
Ensembl Acc Id:
ENSP00000420784 ⟸ ENST00000473453
RGD ID: 6804904
Promoter ID: HG_KWN:52257
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: HeLa_S3, Lymphoblastoid
Transcripts: OTTHUMT00000039793
Position: Human Assembly Chr Position (strand) Source Build 36 6 7,833,991 - 7,835,642 (-) MPROMDB
RGD ID: 6804905
Promoter ID: HG_KWN:52258
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: CD4+TCell, CD4+TCell_12Hour, HeLa_S3, K562, Lymphoblastoid, NB4
Transcripts: OTTHUMT00000039792, UC010JNZ.1, UC010JOA.1
Position: Human Assembly Chr Position (strand) Source Build 36 6 7,855,166 - 7,856,782 (-) MPROMDB
RGD ID: 6871988
Promoter ID: EPDNEW_H9159
Type: initiation region
Name: TXNDC5_4
Description: thioredoxin domain containing 5
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H9161 EPDNEW_H9160 EPDNEW_H9162
Experiment Methods: Single-end sequencing.; Paired-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 6 7,884,415 - 7,884,475 EPDNEW
RGD ID: 6871994
Promoter ID: EPDNEW_H9160
Type: initiation region
Name: TXNDC5_3
Description: thioredoxin domain containing 5
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H9159 EPDNEW_H9161 EPDNEW_H9162
Experiment Methods: Single-end sequencing.; Paired-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 6 7,895,104 - 7,895,164 EPDNEW
RGD ID: 6871992
Promoter ID: EPDNEW_H9161
Type: initiation region
Name: TXNDC5_2
Description: thioredoxin domain containing 5
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H9159 EPDNEW_H9160 EPDNEW_H9162
Experiment Methods: Single-end sequencing.; Paired-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 6 7,904,590 - 7,904,650 EPDNEW
RGD ID: 6804483
Promoter ID: HG_KWN:52262
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4
Transcripts: ENST00000397456, ENST00000397457, NM_201280, UC003MXW.1, UC010JOB.1, UC010JOC.1
Position: Human Assembly Chr Position (strand) Source Build 36 6 8,009,354 - 8,009,854 (-) MPROMDB
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-04-12
TXNDC5
thioredoxin domain containing 5
thioredoxin domain containing 5 (endoplasmic reticulum)
Symbol and/or name change
5135510
APPROVED